The Dual Syk/JAK Inhibitor Cerdulatinib Antagonizes B-cell Receptor and Microenvironmental Signaling in Chronic Lymphocytic Leukemia
Matthew D. Blunt(University of Southampton), Andrew J. Steele(Carnegie Institution for Science)
Cited by 64
Related Papers
Selinexor Enhances NK Cell Activation Against Malignant B Cells via Downregulation of HLA-E
|Frontiers in Oncology|2021|22